Science Journal

 

 Cancer Biology

 

ISSN: 2150-1041 (print); ISSN: 2150-105X (online), doi prefix:10.7537, Quarterly

 
Volume 7 / Issue 4, Cumulated No. 28, 25, 2017
Cover (jpg), Cover (pdf), Introduction, Contents

 

The following manuscripts are presented as online first for peer-review, starting from October 20, 2017. 

All comments are welcome: editor@sciencepub.net or contact with author(s) directly.

 

You can use the message in end of the article abstract to cite it.

To get Microsoft Documents: After you open the "Full Text" for each article, change the last 3 characters of the web address from .pdf to .doc (or .docx)

Welcome to send your manuscript to: sciencepub@gmail.com

When you submit manuscript(s), please mention that it is submitted to the Cancer Biology.

Marsland Press, PO Box 180432, Richmond Hill, New York 11418, USA, 347-321-7172

http://www.cancerbio.net

  

CONTENTS  

No.

Titles / Authors /Abstracts

Full Text

No.

1

Use of Vinorelbine/Cisplatin regimen Versus Docetaxel/Gemcitabine regimen in Operable Locally Advanced Breast Cancer Patients

 

Muhammad Solaiman Muhammad, Maha Lotfy Zamzam, Ahmed Mostafa Elzawawy and Ehab Mohammed Hassanen

 

Clinical Oncology & Nuclear Medicine Department, Faculty of Medicine, Suez Canal University, Egypt.

mahalzamzam@hotmail.com

 

Abstract: Background: Locally advanced breast cancer continues to be a common breast cancer presentation worldwide and to be a significant problem in Egypt. The National Cancer Institute of Cairo data showed breast cancer stages III and IV to be around 80 - 90%. Aim of Work: To compare the Response Rate & Toxicity of using Vinorelbine/Cisplatin regimen versus Docetaxel/Gemcitabine regimen as a tool of treatment in Operable Locally Advanced Breast Cancer patients. Patients & Methods: This was a randomized clinical trial study that was conducted upon clinically, pathologically & radiologically proved patients with Locally Advanced Breast Cancer attending Clinical Oncology and Nuclear Medicine Department of Suez Canal University during 2013 & 2014 at Ismailia. Patients recruited for the study were divided into two main groups as follows: Group (1): included patients who received 4 cycles of (Vinorelbine, Cisplatin) regimen. Group (2): included patients who received 4 cycles of (Docetaxel, Gemcitabine) regimen. Results: (Vinorelbine, Cisplatin) regimen was more effective and well-tolerated than (Docetaxel, Gemcitabine) regimen in patients with Locally Advanced Breast Cancer with Overall Response Rate: (84.44%, 53.33%) respectively. Disease Free Survival & Overall Survival for those who had pathological complete tumor & nodal response after receiving either (Vinorelbine, Cisplatin) or (Docetaxel, Gemcitabine) regimens during 19 months of follow-up were (100%) with significant statistical difference. Conclusion: Pathological complete remission to neoadjuvant chemotherapy has been consistently associated with improved disease free survival and overall survival.

[Muhammad Solaiman Muhammad, Maha Lotfy Zamzam, Ahmed Mostafa Elzawawy and Ehab Mohammed Hassanen. Use of Vinorelbine/Cisplatin regimen Versus Docetaxel/Gemcitabine regimen in Operable Locally Advanced Breast Cancer Patients. Cancer Biology 2017;7(4):1-10]. ISSN: 2150-1041 (print); ISSN: 2150-105X (online). http://www.cancerbio.net. 1. doi:10.7537/marscbj070417.01.

 

Key Words: Response rate, toxicity, overall survival, disease free survival & Pathological complete remission.

Full Text

1

2

Exploratory Results of Capecitabine Metronomic Chemotherapy in Metastatic Breast Cancer Patients after Prior Systemic Therapy for Metastatic Disease– A -Arm Phase II Study

 

Mohamed Sheta, MD, Rasha Abd El-Ghany Khedr, MD

 

Department of Clinical Oncology, Tanta University Hospital, Tanta, Egypt

Mohamed_sheta1@yahoo.com

 

Abstract: Purpose: The aim of this study is to investigate efficacy and toxicity of Capecitabine metronomic therapy preceded by prior treatment with at least one drug regimen for metastatic disease. Methods: Between June 2013 and February 2015, 38 women with pathologically proven metastatic breast cancer (MBC) with at least one significant lesion, who had received prior chemotherapy for metastatic disease, were enrolled. Patients received oral Capecitabine (Xeloda) metronomic therapy (750 mg/m2, twice every day). The primary endpoints of this study were progression-free survival (PFS) rates and safety profile. Secondary end points were tumor response and overall survival (OS). Results: Objective response was observed in 23.7% of patients (9/38), and tumor control rate was 84.2% (32/38). Complete response was observed in 2 patients (5.3%) following treatment. The estimated median PFS and OS were 9 and 18 months, respectively. The 1-year OS and PFS rates were 73.6% and 42.1%, respectively. Treatment-related adverse events were manageable with only 2 patients (5.3%) suffered from Grade 3/4 hand-foot syndrome and another 2 patients (5.3%) suffered from Grade 3 diarrhea. No Grade 3/4 hematologic toxicity was recorded. All patients received full doses of Capecitabine and dose reduction was not required in any of our patients throughout the study. Conclusions: Capecitabine metronomic therapy in MBC patients after prior chemotherapy in metastatic setting offered a promising clinical benefit and simple way to be administered in outpatients, to the degree that makes it not only feasible, but also may be surpassed by the patients.

[Mohamed Sheta, Rasha Abd El-Ghany Khedr. Exploratory Results of Capecitabine Metronomic Chemotherapy in Metastatic Breast Cancer Patients after Prior Systemic Therapy for Metastatic Disease– A -Arm Phase II Study. Cancer Biology 2017;7(4):11-18]. ISSN: 2150-1041 (print); ISSN: 2150-105X (online). http://www.cancerbio.net. 2. doi:10.7537/marscbj070417.02.

 

Key words: Metastatic breast cancer, capecitabine metronomic therapy.

Full Text

2

3

Comparison of the anticancer effects of Panobinostat with doxorubicin on diethylnitrosamine induced hepatocellular carcinoma

 

Neimat A Yassin1, Aml A Mahmoud 2, Asmaa M Elhoseiny3

 

1Assistant lecturer in Clinical Pharmacology Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt

2Veterinarian in Mansoura Experimental and Research Center, Mansoura, Egypt

3 Assistant lecturers in Histology Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt

dr_nona82@yahoo.com

 

Abstract: Panobinostat is the most recent histone deacetylase inhibitor approved for treatment of relapsed and recurrent multiple myeloma. In this study we compare its effects with doxorubicin which is already used for trans-arterial chemoembolization of hepatocellular carcinoma (HCC). Methods: anti-cancer effects of panobinostat and doxorubicin are tested in DENA induced HCC in rats by pathological examination of liver sections and measuring liver enzymes Results: Panobinostat was found to highly significantly inhibit Heppar-1 and VEGF levels and both drugs decrease ALT levels while AST was increased in panobinostat groups. Conclusion: These results suggest that panobinostat may be a potent alternative to doxorubicin for treatment of HCC.

[Neimat A Yassin, Aml A Mahmoud, Asmaa M Elhoseiny. Comparison of the anticancer effects of Panobinostat with doxorubicin on diethylnitrosamine induced hepatocellular carcinoma. Cancer Biology 2017;7(4):19-28]. ISSN: 2150-1041 (print); ISSN: 2150-105X (online). http://www.cancerbio.net. 3. doi:10.7537/marscbj070417.03.

 

Keywords: Panobinostat, Hepatocellular carcinoma, Doxorubicin, Diethylnitrosamine

Full Text

3

4

Review on therapeutic and medicinal use of aloevera

 

Tesfahun Terefe and Tsehaye Neges

 

Candidates of veterinary Medicine, Collage of Veterinary medicine and Animal Sciences, University of Gondar, Ethiopia

Email: thesunneges@gmail.com

 

AbstractThis paper is mainly aimed to review the therapeutic and medicinal use of aloevera. The aloe vera or succulent has a long history of being used for medicinal purposes, dating back to ancient Egypt. The plant is native to North Africa, Southern Europe, and the Canary Islands. It’s used in traditional Indian medicine for constipation, skin diseases, worm infestation, infections and as natural remedy for colic. In Chinese medicine, it’s often recommended in the treatment of fungal diseases, and in the Western world, it has found widespread use in the cosmetic, pharmaceutical and food industries. The plant Aloe vera is used in Ayurvedic, Homoeopathic and Allopathic streams of medicine, and not only tribal community but also most of the people for food and medicine. The plant leaves contains numerous vitamins, minerals, enzymes, amino acids, natural sugars and other bioactive compounds with emollient, purgative, anti-microbial, anti inflammatory, antioxidant, aphrodisiac, anti-helmenthic, antifungal, antiseptic and cosmetic values for health care. This plant has potential to cure sunburns, burns and minor cuts, and even skin cancer. The external use in cosmetic primarily acts as skin healer and prevents injury of epithelial tissues, cures acne and gives a youthful glow to skin, also acts as extremely powerful laxative. As aloevera has a great therapeutic and medicinal value, therefore; it is better to use herbal medicine in modern ways rather than using traditional methods.

[Tesfahun Terefe and Tsehaye Neges. Review on therapeutic and medicinal use of aloevera. Cancer Biology 2017;7(4):29-38]. ISSN: 2150-1041 (print); ISSN: 2150-105X (online). http://www.cancerbio.net. 4. doi:10.7537/marscbj070417.04.

 

Keywords: Adverse reactions; Aloe Vera; Antimicrobial; Medicinal Uses; Therapeutic

Full Text

4

5

Use of immobilized Bacillus subtilis natto cells in calcium alginate matrices on MK-7 production

 

Raja Mahanama, Aydin Berenjian, John Kavanagh, Fariba Dehghani

 

School of Chemical and Bimolecular Engineering, The University of Sydney, Sydney, NSW 2006, Australia

aydin.berenjian@sydney.edu.au

 

Abstract: Menaquinone-7 (MK-7) a K vitamer has shown significant effects on preventing cardiovascular and osteoporosis, and hence is of industrial/pharmaceutical interest. Bacillus subtilis natto is known to produce via free floating fermentation. On the other hand, cell immobilization technique due to its high stability against contamination, easier product recovery and high productivity attracted attention for producing many fermentation processes. Therefore, to optimize MK-7 production it is critical to understand the effect of immobilization on MK-7 formation.

[Raja Mahanama, Aydin Berenjian, John Kavanagh, Fariba Dehghani. Use of immobilized Bacillus subtilis natto cells in calcium alginate matrices on MK-7 production. Cancer Biology 2017;7(4):39-41]. ISSN: 2150-1041 (print); ISSN: 2150-105X (online). http://www.cancerbio.net. 5. doi:10.7537/marscbj070417.05.

 

Keywords: Menaquinone-7, Bacillus subtilis natto, immobilization.

Full Text

5

6

Study of the “Unculi” of Pseudocheneis sulcatus (McClelland) (Sisoridae) fish of Kumaun Himalaya

 

S.C. Joshi, Ila Bisht and S.K. Agarwal

 

Department of Zoology, Kumaun University, S.S.J. Campus, Almora – 263 601, India.

Sureshjoshi2007@yahoo.com, joshi.drsuresh301@gmail.com; Cellular phone: 9720250733.

 

Abstract: Different type of unculi in the general body epidermis, snout epidermis, lip epidermis, adhesive apparatus epidermis and paired fin epidermis of Pseudocheneis sulcatus (McClelland) (Sisoridae) have been characterized by using scanning electron microscopy techniques in an attempt to understand their functional significance in relation to friction. The epidermis is differentiated into rough and smooth P. sulcatus. The rough epidermis consists of the epithelial cells. The smooth epidermis in addition to these cells type also possesses mucous cells. The surface of rough epidermis and smooth epidermis of P. sulcatus are keratinized in nature, in the rough epidermis, the epithelial cell surfaces are modifying into epidermal growth the unculi. The present investigation shows that, P. sulcatus GBE, snout and lips are non-papilliated with uncular surface and the adhesive apparatus and fin epidermis are papilliated.

[S.C. Joshi, Ila Bisht and S.K. Agarwal. Study of the “Unculi” of Pseudocheneis sulcatus (McClelland) (Sisoridae) fish of Kumaun Himalaya. Cancer Biology 2017;7(4):42-47]. ISSN: 2150-1041 (print); ISSN: 2150-105X (online). http://www.cancerbio.net. 6. doi:10.7537/marscbj070417.06.

 

Key word: Epidermal unculi, Kumaun Himalaya, Hill-stream fish, P. sulcatus and SEM.

Full Text

6

7

Sensitivity of Staphylococcus aureus isolated from subclinical bovine mastitis to Ciprofloxacin in Tabriz dairy herd in 2012

Jalili T1ᵒ, Mosaferi S2, Shirafkan A3, Asfaram H 1, Khakpour M2

1- Student of Veterinary Medicine, Yong Researchers Club, Tabriz Branch, Islamic Azad University, Tabriz, Iran
2- Department of Clinical Sciences, Faculty of Veterinary Medicine, Tabriz Branch, Islamic Azad University, Tabriz, Iran
3- DVM, Department of Veterinary Medicine, Yong Researchers Club, Tabriz Branch, Islamic Azad University, Tabriz, Iran
* Corresponding authors E-mail: tohid.jalili@yahoo.com

 

Abstract: Mastitis is an inflammation of the parenchyma of mammary gland regardless of the causes. Mastitis is characterized by a range of physical and chemical changes in the glandular tissue. The most important changes in milk include discoloration, the present clots and the present of large number of leucocytes. There is a swelling, heat, pain and edema in mammary gland in many clinical causes. Coagulase positive S. aurousis a major pathogen of the bovine mammary gland and a common cause of contagious mastitis in cattle. The aim of this study was the evaluation of outbreaks of Staphylococcus aurous mastitis and its sensitivity to Ciprofloxacin in Tabriz dairy herd. This study is conducted in ten dairy herd of Tabriz on about one thousand cows. After doing CMT and identifying of infected cows, the milk samples obtained from infected quarters and transport to microbiological laboratories. After microbial culture of milk samples and isolated of S. aurous, antimicrobial sensitivity test with disk diffusion method perform by Ciprofloxacin, Penicillin, Oxytetracyclin, Co-trimoxazole, lincomycin and Cefquinome. This study defined that the outbreak of subclinical coagolase positive staphylococcus mastitis in Tabriz dairy herd was4.43 % (3.35 % S. aureus and 1.08 % S. intermedicus). The antimicrobial sensitivity test shown that88.23% of Staphylococcus aureus isolated from bovine mastitis in Tabriz dairy herd were susceptible to Ciprofloxacin, 94.1% to Cefquinome,, 85.29 to Sulfonamides (Co-trimoxazole), 32.35 lincomycin, 14.7% to Oxytetracyclin and 5.88% to penicillin. Results of this study defined that Ciprofloxacin has a great effect on Staphylococcus aureus isolated from subclinical bovine mastitis at in vivo.
[Jalili T, Mosaferi S, Shirafkan A, Asfaram H, Khakpour M. Sensitivity of Staphylococcus aureus isolated from subclinical bovine mastitis to Ciprofloxacin in Tabriz dairy herd in 2012. Cancer Biology 2017;7(4):48-52]. ISSN: 2150-1041 (print); ISSN: 2150-105X (online). http://www.cancerbio.net. 7. doi:10.7537/marscbj070417.07.

Keywords: Mastitis, Staphylococcus aurous, Ciprofloxacin.

Full Text

7

8

Vitamin H And Hteir Role In Ruminant: A Review

Hamed Amini Pour

Young Researchers Club, Sarab Branch, Islamic Azad University, Sarab, Iran.
khamed_jackson@yahoo.com

 

Abstract: Biotin, also known as Vitamin H or Coenzyme R, is a water-soluble B-complex vitamin founded with Bateman in 1916. It is composed of an uredo ring fused by a tetrahydrothiophene ring. A valeric acid substituent is attached to one of the carbon atoms of the tetra hydrothiophene ring. Biotin is a coenzyme in the metabolism of fatty acids, isoleucine, and valine, and it plays a role in gluconeogenesis. Biotin is vital for cell growth, the production of fatty acids, and the metabolism of fats and amino acids. It plays a role in the citric acid cycle, that is the process with which biochemical energy is generated during aerobic respiration. Biotin not only assists in diversion metabolic reactions but also helps to transfer carbon dioxide. Biotin may also be helpful in keeping a steady blood sugar level. Biotin is often advocated for strengthening hair and nails. As a consequence, it is found in many cosmetics and health products for the hair and skin, though it cannot be absorbed through the hair or skin itself. Biotin scarcity is rare because, in general, intestinal bacteria produce biotin in excess of the body's daily requirements. For which reason, statutory agencies in many countries, for example the USA and Australia, don't prescribe an advocated daily intake of biotin. Therefore, a number of metabolic disorders in that an individual's metabolism of biotin is abnormal exist. Incidence of biotin scarcity has-been found occasionally when humans and animals have consumed excessive quantities of raw eggs that contain a biotin completing factor (avidin). Likewise, biotin scarcity is reported in children by inborn errors of metabolism when there are insufficient biotin-dependent enzymes. Such cases in children respond dramatically to high-level dietary supplementations by biotin.
[Hamed Amini Pour. Vitamin H And Hteir Role In Ruminant: A Review. Cancer Biology 2017;7(4):53-56]. ISSN: 2150-1041 (print); ISSN: 2150-105X (online). http://www.cancerbio.net. 8. doi:10.7537/marscbj070417.08.

Keywords: Vitamin H; Hteir Role; Ruminant; Review

Full Text

8

9

RapidArc versus intensity modulated radiation therapy in adjuvant gastric cancer irradiation: Any dosimetric advantage?

 

Karim Mashhour, M.D *, Wedad Hashem, M.D *, Hoda Abdelghany, M.sc †,

 

*Department of Clinical Oncology, Kasr Al-Ainy school of medicine, Cairo University, Cairo, 11553, EgyptFax number: 37606512 - 37490002

E-mail: karim.mashhour.81@gmail.com; Tel. (+20) 1006086827

Department of medical physics, Kasr Al-Ainy Hospital, Cairo University, Egypt

 

Abstract: Background: The purpose was to compare dosimetrically intensity modulated radiation therapy (IMRT) and RapidArc (RA) techniques for gastric carcinoma patients. Methods: For IMRT, a coplanar seven-field plan was performed. Regarding the RA, plans were done using a double arc plan consisting of 2 co-planar arcs of 360 in clockwise & counter clockwise direction. The PTV dose coverage criteria was at least 95% of PTV received 45Gy. Results: The mean V95 was 94.7% and 94.8% for the IMRT and RA, respectively (p = 0.32). The CI for IMRT and RA were 0.93 0.01 & 0.94 0.01, respectively; while the HI was 1.153 0.01 for IMRT & 1.142 0.02 for RA (both p > 0.04). The maximum spinal cord dose for IMRT and RapidArc was 37.87 Gy vs 36.42 Gy (p = 0.34). For the right kidney, IMRT had significantly lower mean V20 compared to RA (22.2 vs. 24.3Gy, p = 0.01). The mean V20 to the left kidney were 24.4 and 23.4 Gy in the IMRT and RA (p = 0.01). The treatment time was 193.5 25.0s in IMRT and 66.0 8.7 s in RA (p = 0.002). The total monitor units (MU) for RA and IMRT were 343.0 94.0 & 363.0 44.0 (p = 0.07), respectively. Conclusions: RA obtained similar dosimetric outcomes to IMRT plans regarding target coverage & organs at risk (OAR) sparing with an advantage of shorter delivery time & lower number of MU.

[Karim Mashhour, Wedad Hashem, Hoda Abdelghany. RapidArc versus intensity modulated radiation therapy in adjuvant gastric cancer irradiation: Any dosimetric advantage?. Cancer Biology 2017;7(4):57-64]. ISSN: 2150-1041 (print); ISSN: 2150-105X (online). http://www.cancerbio.net. 9. doi:10.7537/marscbj070417.09.

 

Keywords: dosimetric, double arc, IMRT, MUs

Full Text

9

10

Myelo-protective Activity of Crude Methanolic Extract of Leaves of Gongronema latifolium in Cyclophosphamide-induced Myelo-suppression.

 

Ufelle, S. A1, Ukaejiofo, E. O1, Achukwu, P.U1, Ghasi, S2

 

1.Department of Medical Laboratory Sciences, Faculty of Health Sciences and Technology, College of Medicine, University of Nigeria Enugu Campus (UNEC) Enugu State, Nigeria.

2.Department of Pharmacology and Therapeutics, College of Medicine, University of Nigeria Enugu Campus (UNEC) Enugu State, Nigeria

silasufelle@hahoo.com

 

Abstract: This study was designed to investigate the myelo-protective activity of crude methanolic extract of Gongronema latifolium leaves in cyclophosphamide-induced myelo-suppression. Wistar rats [n=30], aged 2 to 3 months, weighing 120 to 170 grams were acclimatized for two weeks and fed with commercially available rat feed and had access to water and feed ad libitum. They were divided into 5 groups [A to E]. Groups A, B and C were intraperitoneally-induced for myelo-suppression with 3mg/kg bodyweight of cyclophosphamide for 7 days. After induction, A served as cyclophosphamide-induced control, B received 150mg/kg, C received 250mg/kg and D [non-induced] received 250mg/kg [body-weight] of the extract orally for 14 days. Group E served as non-induced control. Blood samples [3.0 ml] were collected from each rat on days 8 and 15 through the retro orbital plexus of the median canthus into tri-potassium ethylene-diamine-tetracetic-acid containers for haematological analysis. Day 8, groups B and C revealed dosage-dependent significantly increased values compared to A [p<0.05] while D revealed non-significantly increased values compared to E. Day 15 groups B and C revealed dosage- and time-dependent significantly increased values compared to A while D revealed time-dependent significantly increased values compared to E. This suggests that this extract may posses’ both myelo-protective and haematopoietic effects when orally administered in cyclophosphamide-induced myelo-suppressed and non-induced Wistar rats.

[Ufelle, S. A, Ukaejiofo, E. O, Achukwu, P.U, Ghasi, S. Myelo-protective Activity of Crude Methanolic Extract of Leaves of Gongronema latifolium in Cyclophosphamide-induced Myelo-suppression.. Cancer Biology 2017;7(4):65-68]. ISSN: 2150-1041 (print); ISSN: 2150-105X (online). http://www.cancerbio.net. 10. doi:10.7537/marscbj070417.10.

 

Keywords: Ad libitum; Dosage- and Time-dependent; Haematopoietic; Intraperitoneally; Orally.

Full Text

10

11

 

Full Text

11

12

 

Full Text

12

13

 

Full Text

13

14

 

Full Text

14

15

 

Full Text

15

16

 

Full Text

16

17

 

Full Text

17

18

 

Full Text

18

19

 

Full Text

19

20

 

Full Text

20

21

 

Full Text

21

22

 

Full Text

22

23

 

Full Text

23

24

 

Full Text

24

25

 

Full Text

25

26

 

Full Text

26

27

 

Full Text

27

28

 

Full Text

28

29

 

Full Text

29

30

 

Full Text

30

31

 

Full Text

31

32

 

Full Text

32

33

 

Full Text

33

34

 

Full Text

34

35

 

Full Text

35

36

 

Full Text

36

37

 

Full Text

37

38

 

Full Text

38

39

 

Full Text

39

40

 

Full Text

40

41

 

Full Text

41

42

 

Full Text

42

43

 

Full Text

43

44

 

Full Text

44

45

 

Full Text

45

46

 

Full Text

46

47

 

Full Text

47

48

 

Full Text

48

49

 

Full Text

49

50

 

Full Text

50

51

 

Full Text

51

52

 

Full Text

52

53

 

Full Text

53

54

 

Full Text

54

55

 

Full Text

55

56

 

Full Text

56

57

 

Full Text

57

58

 

Full Text

58

59

 

Full Text

59

60

 

Full Text

60

61

 

Full Text

61

62

 

Full Text

62

63

 

Full Text

63

64

 

Full Text

64

65

 

Full Text

65

66

 

Full Text

66

67

 

Full Text

67

68

 

Full Text

68

69

 

Full Text

69

70

 

Full Text

70

71

 

Full Text

71

72

 

Full Text

72

73

 

Full Text

73

74

 

Full Text

74

75

 

Full Text

75

76

 

Full Text

76

77

 

Full Text

77

78

 

Full Text

78

79

 

Full Text

79

80

 

Full Text

80

81

 

Full Text

81

82

 

Full Text

82

83

 

Full Text

83

84

 

Full Text

84

85

 

Full Text

85

86

 

Full Text

86

87

 

Full Text

87

88

 

Full Text

88

89

 

Full Text

89

90

 

Full Text

90

91

 

Full Text

91

92

 

Full Text

92

93

 

Full Text

93

94

 

Full Text

94

95

 

Full Text

95

96

 

Full Text

96

97

 

Full Text

97

98

 

Full Text

98

99

 

Full Text

99

100

 

Full Text

100

101

 

Full Text

101

102

 

Full Text

102

103

 

Full Text

103

104

 

Full Text

104

105

 

Full Text

105

106

 

Full Text

106

107

 

Full Text

107

108

 

Full Text

108

109

 

Full Text

109

110

 

Full Text

110

111

 

Full Text

111

112

 

Full Text

112

113

 

Full Text

113

114

 

Full Text

114

115

 

Full Text

115

116

 

Full Text

116

117

 

Full Text

117

118

 

Full Text

118

119

 

Full Text

119

120

 

Full Text

120

121

 

Full Text

121

122

 

Full Text

122

123

 

Full Text

123

124

 

Full Text

124

125

 

Full Text

125

126

 

Full Text

126

127

 

Full Text

127

128

 

Full Text

128

129

 

Full Text

129

130

 

Full Text

130

131

 

Full Text

131

132

 

Full Text

132

133

 

Full Text

133

134

 

Full Text

134

135

 

Full Text

135

136

 

Full Text

136

137

 

Full Text

137

138

 

Full Text

138

139

 

Full Text

139

140

 

Full Text

140

141

 

Full Text

141

142

 

Full Text

142

143

 

Full Text

143

144

 

Full Text

144

145

 

Full Text

145

146

 

Full Text

146

147

 

Full Text

147

148

 

Full Text

148

149

 

Full Text

149

150

 

Full Text

150

151

 

Full Text

151

152

 

Full Text

152

153

 

Full Text

153

154

 

Full Text

154

155

 

Full Text

155

156

 

Full Text

156

157

 

Full Text

157

158

 

Full Text

158

159

 

Full Text

159

160

 

Full Text

160

161

 

Full Text

161

162

 

Full Text

162

163

 

Full Text

163

164

 

Full Text

164

165

 

Full Text

165

166

 

Full Text

166

167

 

Full Text

167

168

 

Full Text

168

169

 

Full Text

169

170

 

Full Text

170

171

 

Full Text

171

172

 

Full Text

172

173

 

Full Text

173

174

 

Full Text

174

175

 

Full Text

175

176

 

Full Text

176

177

 

Full Text

177

178

 

Full Text

178

179

 

Full Text

179

180

 

Full Text

180

181

 

Full Text

181

182

 

Full Text

182

183

 

Full Text

183

184

 

Full Text

184

185

 

Full Text

185

186

 

Full Text

186

187

 

Full Text

187

188

 

Full Text

188

189

 

Full Text

189

190

 

Full Text

190

191

 

Full Text

191

192

 

Full Text

192

193

 

Full Text

193

194

 

Full Text

194

195

 

Full Text

195

196

 

Full Text

196

197

 

Full Text

197

198

 

Full Text

198

199

 

Full Text

199

200

 

Full Text

200

201

 

Full Text

201

202

 

Full Text

202

203

 

Full Text

203

204

 

Full Text

204

205

 

Full Text

205

206

 

Full Text

206

207

 

Full Text

207

208

 

Full Text

208

209

 

Full Text

209

210

 

Full Text

210

211

 

Full Text

211

212

 

Full Text

212

213

 

Full Text

213

214

 

Full Text

214

215

 

Full Text

215

216

 

Full Text

216

217

 

Full Text

217

218

 

Full Text

218

219

 

Full Text

219

220

 

Full Text

220

221

 

Full Text

221

222

 

Full Text

222

223

 

Full Text

223

224

 

Full Text

224

225

 

Full Text

225

226

 

Full Text

226

227

 

Full Text

227

228

 

Full Text

228

229

 

Full Text

229

230

 

Full Text

230

231

 

Full Text

231

232

 

Full Text

232

233

 

Full Text

233

234

 

Full Text

234

235

 

Full Text

235

236

 

Full Text

236

237

 

Full Text

237

238

 

Full Text

238

239

 

Full Text

239

240

 

Full Text

240

241

 

Full Text

241

242

 

Full Text

242

243

 

Full Text

243

244

 

Full Text

244

245

 

Full Text

245

246

 

Full Text

246

247

 

Full Text

247

248

 

Full Text

248

249

 

Full Text

249

250

 

Full Text

250

251

 

Full Text

251

252

 

Full Text

252

253

 

Full Text

253

254

 

Full Text

254

255

 

Full Text

255

256

 

Full Text

256

257

 

Full Text

257

258

 

Full Text

258

259

 

Full Text

259

260

 

Full Text

260

261

 

Full Text

261

262

 

Full Text

262

263

 

Full Text

263

264

 

Full Text

264

265

 

Full Text

265

266

 

Full Text

266

267

 

Full Text

267

268

 

Full Text

268

269

 

Full Text

269

270

 

Full Text

270

271

 

Full Text

271

272

 

Full Text

272

273

 

Full Text

273

274

 

Full Text

274

275

 

Full Text

275

276

 

Full Text

276

277

 

Full Text

277

278

 

Full Text

278

279

 

Full Text

279

280

 

Full Text

280

281

 

Full Text

281

282

 

Full Text

282

283

 

Full Text

283

284

 

Full Text

284

285

 

Full Text

285

286

 

Full Text

286

287

 

Full Text

287

288

 

Full Text

288

289

 

Full Text

289

290

 

Full Text

290

291

 

Full Text

291

292

 

Full Text

292

293

 

Full Text

293

294

 

Full Text

294

295

 

Full Text

295

296

 

Full Text

296

297

 

Full Text

297

298

 

Full Text

298

299

 

Full Text

299

300

 

Full Text

300

301

 

Full Text

301

302

 

Full Text

302

303

 

Full Text

303

304

 

Full Text

304

305

 

Full Text

305

306

 

Full Text

306

307

 

Full Text

307

308

 

Full Text

308

309

 

Full Text

309

310

 

Full Text

310

311

 

Full Text

311

312

 

Full Text

312

313

 

Full Text

313

314

 

Full Text

314

315

 

Full Text

315

316

 

Full Text

316

317

 

Full Text

317

318

 

Full Text

318

319

 

Full Text

319

320

 

Full Text

320

321

 

Full Text

321

322

 

Full Text

322

323

 

Full Text

323

324

 

Full Text

324

325

 

Full Text

325

326

 

Full Text

326

327

 

Full Text

327

328

 

Full Text

328

329

 

Full Text

329

330

 

Full Text

330

331

 

Full Text

331

332

 

Full Text

332

333

 

Full Text

333

334

 

Full Text

334

335

 

Full Text

335

336

 

Full Text

336

337

 

Full Text

337

338

 

Full Text

338

339

 

Full Text

339

340

 

Full Text

340

341

 

Full Text

341

342

 

Full Text

342

343

 

Full Text

343

344

 

Full Text

344

345

 

Full Text

345

346

 

Full Text

346

347

 

Full Text

347

348

 

Full Text

348

349

 

Full Text

349

350

 

Full Text

350

351

 

Full Text

351

352

 

Full Text

352

353

 

Full Text

353

354

 

Full Text

354

355

 

Full Text

355

356

 

Full Text

356

357

 

Full Text

357

358

 

Full Text

358

359

 

Full Text

359

360

 

Full Text

360

361

 

Full Text

361

362

 

Full Text

362

363

 

Full Text

363

364

 

Full Text

364

365

 

Full Text

365

366

 

Full Text

366

367

 

Full Text

367

368

 

Full Text

368

369

 

Full Text

369

370

 

Full Text

370

371

 

Full Text

371

372

 

Full Text

372

373

 

Full Text

373

374

 

Full Text

374

375

 

Full Text

375

376

 

Full Text

376

377

 

Full Text

377

378

 

Full Text

378

379

 

Full Text

379

380

 

Full Text

380

381

 

Full Text

381

382

 

Full Text

382

383

 

Full Text

383

384

 

Full Text

384

385

 

Full Text

385

386

 

Full Text

386

387

 

Full Text

387

388

 

Full Text

388

389

 

Full Text

389

390

 

Full Text

390

391

 

Full Text

391

392

 

Full Text

392

393

 

Full Text

393

394

 

Full Text

394

395

 

Full Text

395

396

 

Full Text

396

397

 

Full Text

397

398

 

Full Text

398

399

 

Full Text

399

400

 

Full Text

400

401

 

Full Text

401

402

 

Full Text

402

403

 

Full Text

403

404

 

Full Text

404

405

 

Full Text

405

406

 

Full Text

406

407

 

Full Text

407

408

 

Full Text

408

409

 

Full Text

409

410

 

Full Text

410

411

 

Full Text

411

412

 

Full Text

412

413

 

Full Text

413

414

 

Full Text

414

415

 

Full Text

415

416

 

Full Text

416

417

 

Full Text

417

418

 

Full Text

418

419

 

Full Text

419

420

 

Full Text

420

421

 

Full Text

421

422

 

Full Text

422

423

 

Full Text

423

424

 

Full Text

424

425

 

Full Text

425

426

 

Full Text

426

427

 

Full Text

427

428

 

Full Text

428

429

 

Full Text

429

430

 

Full Text

430

431

 

Full Text

431

432

 

Full Text

432

433

 

Full Text

433

434

 

Full Text

434

435

 

Full Text

435

436

 

Full Text

436

437

 

Full Text

437

438

 

Full Text

438

439

 

Full Text

439

440

 

Full Text

440

441

 

Full Text

441

442

 

Full Text

442

443

 

Full Text

443

444

 

Full Text

444

445

 

Full Text

445

446

 

Full Text

446

447

 

Full Text

447

448

 

Full Text

448

449

 

Full Text

449

450

 

Full Text

450

451

 

Full Text

451

452

 

Full Text

452

453

 

Full Text

453

454

 

Full Text

454

455

 

Full Text

455

456

 

Full Text

456

457

 

Full Text

457

458

 

Full Text

458

459

 

Full Text

459

460

 

Full Text

460

461

 

Full Text

461

462

 

Full Text

462

463

 

Full Text

463

464

 

Full Text

464

465

 

Full Text

465

466

 

Full Text

466

467

 

Full Text

467

468

 

Full Text

468

469

 

Full Text

469

470

 

Full Text

470

471

 

Full Text

471

472

 

Full Text

472

473

 

Full Text

473

474

 

Full Text

474

475

 

Full Text

475

476

 

Full Text

476

477

 

Full Text

477

478

 

Full Text

478

479

 

Full Text

479

480

 

Full Text

480

481

 

Full Text

481

482

 

Full Text

482

483

 

Full Text

483

484

 

Full Text

484

485

 

Full Text

485

486

 

Full Text

486

487

 

Full Text

487

488

 

Full Text

488

489

 

Full Text

489

490

 

Full Text

490

491

 

Full Text

491

492

 

Full Text

492

493

 

Full Text

493

494

 

Full Text

494

495

 

Full Text

495

496

 

Full Text

496

497

 

Full Text

497

498

 

Full Text

498

499

 

Full Text

499

500

 

Full Text

500

501

 

Full Text

501

502

 

Full Text

502

503

 

Full Text

503

504

 

Full Text

504

505

 

Full Text

505

506

 

Full Text

506

507

 

Full Text

507

508

 

Full Text

508

509

 

Full Text

509

510

 

Full Text

510

511

 

Full Text

511

512

 

Full Text

512

513

 

Full Text

513

514

 

Full Text

514

515

 

Full Text

515

516

 

Full Text

516

517

 

Full Text

517

518

 

Full Text

518

519

 

Full Text

519

520

 

Full Text

520

521

 

Full Text

521

522

 

Full Text

522

523

 

Full Text

523

524

 

Full Text

524

525

 

Full Text

525

526

 

Full Text

526

527

 

Full Text

527

528

 

Full Text

528

529

 

Full Text

529

530

 

Full Text

530

531

 

Full Text

531

532

 

Full Text

532

533

 

Full Text

533

534

 

Full Text

534

535

 

Full Text

535

536

 

Full Text

536

537

 

Full Text

537

538

 

Full Text

538

539

 

Full Text

539

540

 

Full Text

540

541

 

Full Text

541

542

 

Full Text

542

543

 

Full Text

543

544

 

Full Text

544

545

 

Full Text

545

546

 

Full Text

546

547

 

Full Text

547

548

 

Full Text

548

549

 

Full Text

549

550

 

Full Text

550

551

 

Full Text

551

552

 

Full Text

552

553

 

Full Text

553

554

 

Full Text

554

555

 

Full Text

555

556

 

Full Text

556

557

 

Full Text

557

558

 

Full Text

558

559

 

Full Text

559

560

 

Full Text

560

561

 

Full Text

561

562

 

Full Text

562

563

 

Full Text

563

564

 

Full Text

564

565

 

Full Text

565

566

 

Full Text

566

567

 

Full Text

567

568

 

Full Text

568

569

 

Full Text

569

570

 

Full Text

570

571

 

Full Text

571

572

 

Full Text

572

573

 

Full Text

573

574

 

Full Text

574

575

 

Full Text

575

576

 

Full Text

576

577

 

Full Text

577

578

 

Full Text

578

579

 

Full Text

579

580

 

Full Text

580

581

 

Full Text

581

582

 

Full Text

582

583

 

Full Text

583

584

 

Full Text

584

585

 

Full Text

585

586

 

Full Text

586

587

 

Full Text

587

588

 

Full Text

588

589

 

Full Text

589

590

 

Full Text

590

591

 

Full Text

591

592

 

Full Text

592

593

 

Full Text

593

594

 

Full Text

594

595

 

Full Text

595

596

 

Full Text

596

597

 

Full Text

597

598

 

Full Text

598

599

 

Full Text

599

600

 

Full Text

600

601

 

Full Text

601

602

 

Full Text

602

603

 

Full Text

603

604

 

Full Text

604

605

 

Full Text

605

606

 

Full Text

606

607

 

Full Text

607

608

 

Full Text

608

609

 

Full Text

609

610

 

Full Text

610

611

 

Full Text

611

612

 

Full Text

612

613

 

Full Text

613

614

 

Full Text

614

615

 

Full Text

615

616

 

Full Text

616

617

 

Full Text

617

618

 

Full Text

618

619

 

Full Text

619

620

 

Full Text

620

621

 

Full Text

621

622

 

Full Text

622

623

 

Full Text

623

624

 

Full Text

624

625

 

Full Text

625

626

 

Full Text

626

627

 

Full Text

627

628

 

Full Text

628

629

 

Full Text

629

630

 

Full Text

630

631

 

Full Text

631

632

 

Full Text

632

633

 

Full Text

633

634

 

Full Text

634

635

 

Full Text

635

636

 

Full Text

636

637

 

Full Text

637

638

 

Full Text

638

639

 

Full Text

639

640

 

Full Text

640

641

 

Full Text

641

642

 

Full Text

642

643

 

Full Text

643

644

 

Full Text

644

645

 

Full Text

645

646

 

Full Text

646

647

 

Full Text

647

648

 

Full Text

648

649

 

Full Text

649

650

 

Full Text

650

651

 

Full Text

651

652

 

Full Text

652

653

 

Full Text

653

654

 

Full Text

654

655

 

Full Text

655

656

 

Full Text

656

657

 

Full Text

657

658

 

Full Text

658

659

 

Full Text

659

660

 

Full Text

660

661

 

Full Text

661

662

 

Full Text

662

663

 

Full Text

663

664

 

Full Text

664

665

 

Full Text

665

666

 

Full Text

666

667

 

Full Text

667

668

 

Full Text

668

669

 

Full Text

669

670

 

Full Text

670

671

 

Full Text

671

672

 

Full Text

672

673

 

Full Text

673

674

 

Full Text

674

675

 

Full Text

675

676

 

Full Text

676

677

 

Full Text

677

678

 

Full Text

678

679

 

Full Text

679

680

 

Full Text

680

681

 

Full Text

681

682

 

Full Text

682

683

 

Full Text

683

684

 

Full Text

684

685

 

Full Text

685

686

 

Full Text

686

687

 

Full Text

687

688

 

Full Text

688

689

 

Full Text

689

690

 

Full Text

690

691

 

Full Text

691

692

 

Full Text

692

693

 

Full Text

693

694

 

Full Text

694

695

 

Full Text

695

696

 

Full Text

696

697

 

Full Text

697

698

 

Full Text

698

699

 

Full Text

699

700

 

Full Text

700

701

 

Full Text

701

702

 

Full Text

702

703

 

Full Text

703

704

 

Full Text

704

705

 

Full Text

705

706

 

Full Text

706

707

 

Full Text

707

708

 

Full Text

708

709

 

Full Text

709

710

 

Full Text

710

The manuscripts in this issue were presented as online first for peer-review starting from October 20, 2017

 All comments are welcome: editor@sciencepub.net

For back issues of the Researcher, click here.

Emails: editor@sciencepub.net 

Marsland Press: http://www.sciencepub.net

 

For back issues of the Cancer Biology: click here.

 

 

Marsland Press: http://www.sciencepub.net

 

2017 Marsland Press

 

 

 

 

Web counter since January 1, 2010

daily hits
Quality Inns